| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Bausch & Lomb Selling Itself Away Too Cheap
Posted on 05/17/2007 06:16:37 | Link | Post Comment
by Jon C. Ogg
24/7 Wall St.
Bausch & Lomb (BOL) announced today that it has entered into a definitive merger agreement with affiliates of Warburg Pincus, the global private equity firm. The transaction is valued at approximately $4.5 billion, including approximately $830 million of debt. Bausch & Lomb common stock will be acquired for $65.00 per share in cash.
While this is a tiny premium to today’s price the companies are claiming this is a 26% premium over the volume weighted average price of Bausch & Lomb's shares for 30 days prior to press reports of rumors regarding a potential acquisition.
Bausch & Lomb's Board of Directors, following the recommendation of a Special Committee composed entirely of independent directors, has unanimously approved the agreement and recommends that Bausch & Lomb shareholders approve the merger.
Continue article at 247WallSt.com
___________________
24/7 Wall St.
Bausch & Lomb (BOL) announced today that it has entered into a definitive merger agreement with affiliates of Warburg Pincus, the global private equity firm. The transaction is valued at approximately $4.5 billion, including approximately $830 million of debt. Bausch & Lomb common stock will be acquired for $65.00 per share in cash.While this is a tiny premium to today’s price the companies are claiming this is a 26% premium over the volume weighted average price of Bausch & Lomb's shares for 30 days prior to press reports of rumors regarding a potential acquisition.
Bausch & Lomb's Board of Directors, following the recommendation of a Special Committee composed entirely of independent directors, has unanimously approved the agreement and recommends that Bausch & Lomb shareholders approve the merger.
Continue article at 247WallSt.com
___________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
- The Technical Trader
- Wishing Wealth
- Financial Skeptic
- Don't Mess With Taxes
- Poor and Stupid
- Commodity Option Selling
Examples
ATM Wallstreet - Mon Oct 06, 2008 03:39PM
Made several great trades today. Traded the QID, QQ [read more]
Made several great trades today. Traded the QID, QQ [read more]
ATM Wallstreet - Sat Oct 04, 2008 10:41PM
When I first started Day Trading I traded anything that [read more]
When I first started Day Trading I traded anything that [read more]
ATM Wallstreet - Tue Oct 07, 2008 10:07PM
Today we have the Fed speaking and release of Fed mi [read more]
Today we have the Fed speaking and release of Fed mi [read more]
<< My Home | TheMoneyBlogs Home